Pradžia › Demencija › New Jersey
Demencija klinikiniai tyrimai New Jersey
8 tyrimai dėl Demencija ieško dalyvių vietose New Jersey.
Miestai New Jersey
Oficialus tyrimo tekstas (anglų kalba)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, West Long Branch
Renkami dalyviai2 fazė
Amžius nuo 55 iki 90 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06887192Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons
- Kessler Foundation, East Hanover
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT05048966A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- The Cognitive and Research Center of New Jersey, Springfield
- Advanced Clinical Institute, West Long Branch
Renkami dalyviai3 fazė
Amžius nuo 60 iki 85 · Visoms lytims · Atnaujinta 2026-09-17 · NCT06976203A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- CenExel AMRI, Toms River
Renkami dalyviai1 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-08-24 · NCT06297590A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Advanced Memory Research Institute of New Jersey, Toms River
Renkami dalyviai3 fazė
Amžius nuo 60 iki 85 · Visoms lytims · Atnaujinta 2026-08-20 · NCT06976216A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- The Cognitive and Research Center of New Jersey, Springfield
Renkami dalyviai3 fazė
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-07-07 · NCT07602582Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
- Nuclear Imaging Institute, Englewood
Renkami dalyviai2 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 120 · Visoms lytims · Atnaujinta 2026-04-13 · NCT07012993Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Toms River
Renkami dalyviai2 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-02-02 · NCT07105709Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.